Document is current
Any future updates will be listed below
-
Authors
Cowling, Benjamin J. http://orcid.org/0000-0002-6297-7154
Okoli, George N.
-
Funding
Funding for this research was provided by:
National Institute of General Medical Sciences (R01 GM139926)
University Grants Committee (T11-712/19-N, HKU SRFS2021-7S03)
- License Information
-
More Information
Article History
Accepted: 4 August 2024
First Online: 21 August 2024
Change Date: 21 September 2024
Change Type: Update
Change Details: “An overview of approaches to estimating seasonal influenza vaccine effectiveness (VE)” should has been processed as the section heading
Declarations
:
: B.J.C. has been a consultant for AstraZeneca, Fosun Pharma, GlaxoSmithKline, Haleon, Moderna, Novavax, Pfizer, Roche, and Sanofi Pasteur. G.N.O. reports no potential conflicts of interest.
: This work was supported by the National Institute of General Medical Sciences (grant no. R01 GM139926) and by the Theme-based Research Scheme (Project No. T11-712/19-N) of the Research Grants Council of the Hong Kong Special Administrative Region, China. BJC is supported by an RGC Senior Research Fellowship from the University Grants Committee of Hong Kong (grant number: HKU SRFS2021-7S03).
: B.J.C and G.N.O both contributed equally to this manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
